Recorded Chinese product: 呋喃唑酮片呋喃唑酮片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

呋喃唑酮是一种在国家药监局注册认定的药品。该药品含有呋喃唑酮-83087ab1等成分。

该药品关联的活性成分包括:呋喃唑酮Funan Zuotong。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:甘肃成纪生物药业有限公司Chinese legal name: 甘肃成纪生物药业有限公司。

您可以探索含有相同成分的其他药品:呋喃唑酮-83087ab1成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 呋喃唑酮片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 呋喃唑酮Funan Zuotong.

Manufacturers recorded for this product: 甘肃成纪生物药业有限公司Chinese legal name: 甘肃成纪生物药业有限公司.

Explore other medicines containing the same ingredient: 呋喃唑酮 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 呋喃唑酮片Recorded Chinese product: 呋喃唑酮片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 100mg100 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 甘肃成纪生物药业有限公司Chinese legal name: 甘肃成纪生物药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H62020257

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H62020257

Manufacturer

Chinese legal name: 甘肃成纪生物药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H62020257

生产企业

甘肃成纪生物药业有限公司(国产)

适应症

1.本品主要用于敏感菌所致的细菌性痢疾,肠炎、霍乱。|2.也可以用于伤寒、副伤寒、贾第鞭毛虫病、滴虫病等。|3.与制酸剂等药物合用可治疗幽门螺杆菌所致的胃窦炎。

用法用量

1.口服。成人常用剂量为一次0.1g,一日3-4次。|2.儿童按体重一日5-10mg/kg,分4次服用。|3.肠道感染疗程为5-7日,贾第鞭毛虫病疗程为7-10日。

不良反应

1.主要有恶心,呕吐、腹泻、头痛、头晕、药物热、皮疹、肛门瘙痒、哮喘、直立性低血压、低血糖、肺浸润等。|2.偶可出现溶血性贫血、黄疸及多发性神经炎。

禁忌

对本品过敏者禁用。

注意事项

1.一般不宜用于溃疡病或支气管哮喘患者。|2.口服本品期间饮酒,则可引起双硫仑样反应,表现为皮肤潮红、瘙痒、发热、头痛、恶心、腹痛、心动过速、血压升高、胸闷、烦躁等,故服药期间和停药后5天内,禁止饮酒。|3.葡葡糖-6-磷酸脱氢酶(G-6PD)缺乏者可致溶血性贫血。

贮藏

遮光,密封保存。

规格

100mg

证据Evidence

  • 批准文号: 国药准字H62020257
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.